StreetInsider.com News Articles

Kestra Medical names Daniel Finney VP of research and development

Thu, 10 Sep 2026 06:00:16 -0400

Kestra Medical Technologies (Nasdaq: KMTS) has appointed Daniel Finney as Vice President of Research and Development, adding him to the company's executive leadership team, according to a press release.

Finney succeeds Phillip D. Foshee, Jr., who led Kestra's research and development organization from 2016 until his recent retirement. Foshee oversaw the development of the company's ASSURE wearable cardioverter defibrillator during his tenure.

Finney most recently served as Kestra's Senior Director of New Product Development. He has more than 20 years of experience in Class III medical device development, engineering management, and project management. Before joining Kestra, he held product development roles at

Kestra Names Daniel Finney Vice President of Research & Development

Thu, 10 Sep 2026 06:00:00 -0400

KIRKLAND, Wash., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, announced today that Daniel Finney has been named Vice President of Research & Development and appointed to the company’s executive leadership team.

“Research and development is central to advancing our mission and expanding the role of wearable protection for at-risk patients during critical periods of recovery,” said Brian Webster, President and Chief Executive Officer. “The Cardiac Recovery System® platform was designed from the outset to evolve. Dan’s hands-on role in developing the

Kestra Names Daniel Finney Vice President of Research & Development

Thu, 10 Sep 2026 06:00:00 -0400

Kestra Medical appoints new SVP of customer experience

Wed, 26 Aug 2026 06:00:17 -0400

Kestra Medical Technologies, Ltd. (Nasdaq: KMTS) has appointed Curtis Kopf as Senior Vice President of Customer Experience, a newly created role at the Kirkland, Wash.-based wearable medical device company.

Kopf will oversee the patient experience from order approval through therapy completion and device return for the company's ASSURE® wearable cardioverter defibrillator (WCD).

Kopf previously served as Group Vice President of Global Customer Experience at Insulet Corporation, where he managed a global organization of more than 1,000 employees across digital, customer service, and customer success functions. Before that, he held the roles of Chief Experience Officer and Chief Digital Officer at REI.

"Curtis brings

Kestra Medical appoints new SVP of customer experience

Wed, 26 Aug 2026 06:00:17 -0400

Kopf will oversee the patient experience from order approval through therapy completion and device return for the company's ASSURE® wearable cardioverter defibrillator (WCD).

"Curtis brings

Kestra Appoints Curtis Kopf as Senior Vice President of Customer Experience

Wed, 26 Aug 2026 06:00:00 -0400

KIRKLAND, Wash., Aug. 26, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today announced the appointment of Curtis Kopf as Senior Vice President of Customer Experience. In this newly created role, Mr. Kopf will lead the patient experience from approval of a patient order through completion of therapy and device return, aligning the people, processes and technology that support providers and their patients throughout the use of the ASSURE® WCD.

“Our mission is to provide innovative, intuitive medical technologies to protect and support at-risk

Kestra Appoints Curtis Kopf as Senior Vice President of Customer Experience

Wed, 26 Aug 2026 06:00:00 -0400

“Our mission is to provide innovative, intuitive medical technologies to protect and support at-risk

Kestra Appoints Curtis Kopf as Senior Vice President of Customer Experience

Wed, 26 Aug 2026 06:00:00 -0400

“Our mission is to provide innovative, intuitive medical technologies to protect and support at-risk

Kestra Appoints Curtis Kopf as Senior Vice President of Customer Experience

Wed, 26 Aug 2026 06:00:00 -0400

“Our mission is to provide innovative, intuitive medical technologies to protect and support at-risk

Form 4 KESTRA MEDICAL TECHNOLOG For: Aug 17 Filed by: Webster Brian Daniel

Tue, 18 Aug 2026 19:02:00 -0400

si-local-file:///var/storage/secattach/20260818/26945882.html

Form 4 KESTRA MEDICAL TECHNOLOG For: Aug 17 Filed by: Webster Brian Daniel

Tue, 18 Aug 2026 19:02:00 -0400

si-local-file:///var/storage/secattach/20260818/26945882.html

Form 144 KESTRA MEDICAL TECHNOLOG Filed by: Webster Brian Daniel

Mon, 17 Aug 2026 16:51:00 -0400

si-local-file:///var/storage/secattach/20260817/26938659.html

Form 144 KESTRA MEDICAL TECHNOLOG Filed by: Webster Brian Daniel

Mon, 17 Aug 2026 16:51:00 -0400

si-local-file:///var/storage/secattach/20260817/26938659.html

Form SCHEDULE 13G/A KESTRA MEDICAL TECHNOLOG Filed by: PRICE T ROWE ASSOCIATES INC /MD/

Fri, 14 Aug 2026 10:39:00 -0400

si-local-file:///var/storage/secattach/20260814/26926626.html

Form SCHEDULE 13G/A KESTRA MEDICAL TECHNOLOG Filed by: PRICE T ROWE ASSOCIATES INC /MD/

Fri, 14 Aug 2026 10:39:00 -0400

si-local-file:///var/storage/secattach/20260814/26926626.html

Form 4 KESTRA MEDICAL TECHNOLOG For: Jul 30 Filed by: Moran Timothy P.